Morepen Laboratories Secures Loratadine Approval for Export to China

Morepen Laboratories Limited has achieved a significant milestone by securing approval for the export of Loratadine to China. This approval is part of the company's ongoing efforts to expand its global presence, particularly in the Chinese market. As the largest supplier and manufacturer of Loratadine globally, Morepen continues to strengthen its position in the Active Pharmaceutical Ingredients (API) market. The approval aligns with Morepen's strategy to capitalize on growing demand for Loratadine, which is expected to demonstrate a CAGR of over 2% from FY24-28. This development underscores Morepen's commitment to delivering high-quality products across international markets.

 

Source: Morepen Laboratories Press Release